The renal (myo-)fibroblast: A heterogeneous group of cells

Nephrology Dialysis Transplantation

Volumn 27, Issue 8, 2012, Pages 3027-3036

  Boor, Peter ^a,b   Floege, Jürgen ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b Physics and Informatics   (Slovakia)

Author keywords

kidney development; markers; origin of fibroblasts; renal fibrosis; renal stroma

Indexed keywords

CELL FUNCTION; CHRONIC KIDNEY DISEASE; FIBROBLAST; FIBROGENESIS; HISTOPATHOLOGY; HUMAN; KIDNEY DEVELOPMENT; KIDNEY FIBROBLAST; KIDNEY FIBROSIS; KIDNEY MYOFIBROBLAST; KIDNEY TRANSPLANTATION; LIFE EXPECTANCY; MESENCHYME CELL; NEURAL CREST; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; FIBROBLASTS; FIBROSIS; HUMANS; KIDNEY; MYOFIBROBLASTS; PHENOTYPE; RATS;

EID: 84864595831     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs296     Document Type: Review

References (83)

1. Floege J, Johnson RJ, Feehally J. Comprehensive Clinical Nephrology. St. Louis, MO: Elsevier Saunders, 2010.
2. Boor P, Ostendorf T, Floege J. Renal fibrosis: novel insights into mechanisms and therapeutic targets. Nat Rev Nephrol 2010; 6: 643-656.
3. Boor P, Sebekova K, Ostendorf T et al. Treatment targets in renal fibrosis. Nephrol Dial Transplant 2007; 22: 3391-3407.
4. Boor P, Floege J. Chronic kidney disease growth factors in renal fibrosis. Clin Exp Pharmacol Physiol 2011; 38: 391-400.
5. Vleming LJ, de Fijter JW, Westendorp RG et al. Histomorphometric correlates of renal failure in IgA nephropathy. Clin Nephrol 1998; 49: 337-344.
6. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392-401.
7. Virchow R. Die Cellularpathologie in Ihrer Begruendung auf Physiologische und Pathologische Gewebelehre. Berlin, Germany: Hirschwald, A, 1858.
8. Duvall M. Atlas d'Embryologie. Paris, France: Masson, 1879.
9. Kaissling B, Le Hir M. The renal cortical interstitium: morphological and functional aspects. Histochem Cell Biol 2008; 130: 247-262.
10. Niedermeier M, Reich B, Rodriguez Gomez M et al. CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc Natl Acad Sci USA 2009; 106: 17892-17897.
11. Keeley EC, Mehrad B, Strieter RM. Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis. Int J Biochem Cell Biol 2010; 42: 535-542.
12. Majno G, Gabbiani G, Hirschel BJ et al. Contraction of granulation tissue in vitro: similarity to smooth muscle. Science 1971; 173: 548-550.
13. Eyden B. The myofibroblast: an assessment of controversial issues and a definition useful in diagnosis and research. Ultrastruct Pathol 2001; 25: 39-50.
14. Eyden B. The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J Cell Mol Med 2008; 12: 22-37.
15. Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007; 25: 2896-2902.
16. Crisan M, Yap S, Casteilla L et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008; 3: 301-313.
17. Sommer M, Schaller R, Funfstuck R et al. Abnormal growth and clonal proliferation of fibroblasts in an animal model of unilateral ureteral obstruction. Nephron 1999; 82: 39-50.
18. Pilling D, Fan T, Huang D et al. Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS ONE 2009; 4: e7475.
19. Hinz B. The myofibroblast: paradigm for a mechanically active cell. J Biomech 2010; 43: 146-155.
20. Van Vliet A, Baelde HJ, Vleming LJ et al. Distribution of fibronectin isoforms in human renal disease. J Pathol 2001; 193: 256-62.
21. Thedieck C, Kalbacher H, Kuczyk M et al. Cadherin-9 is a novel cell surface marker for the heterogeneous pool of renal fibroblasts. PLoS ONE 2007; 2: e657.
22. Armulik A, Genove G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 2011; 21: 193-215.
23. Lin SL, Kisseleva T, Brenner DA et al. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008; 173: 1617-1627.
24. Sorrell JM, Caplan AI. Fibroblasts-a diverse population at the center of it all. Int Rev Cell Mol Biol 2009; 276: 161-214.
25. Schmitt-Graff A, Desmouliere A, Gabbiani G. Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity. Virchows Arch 1994; 425: 3-24.
26. Sorrell JM, Caplan AI. Fibroblast heterogeneity: more than skin deep. J Cell Sci 2004; 117(Pt 5): 667-675.
27. Chang HY, Chi JT, Dudoit S et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci USA 2002; 99: 12877-12882.
28. Bachmann S, Le Hir M, Eckardt KU. Co-localization of erythropoietin mRNA and ecto-5?-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J Histochem Cytochem 1993; 41: 335-341.
29. Maxwell PH, Osmond MK, Pugh CW et al. Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 1993; 44: 1149-1162.
30. Paliege A, Rosenberger C, Bondke A et al. Hypoxia-inducible factor-2alpha-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization. Kidney Int 2010; 77: 312-318.
31. Asada N, Takase M, Nakamura J et al. Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice. J Clin Invest 2011; 121: 3981-3990.
32. Zhuo JL. Renomedullary interstitial cells: a target for endocrine and paracrine actions of vasoactive peptides in the renal medulla. Clin Exp Pharmacol Physiol 2000; 27: 465-473.
33. Alcorn D, Maric C, McCausland J. Development of the renal interstitium. Pediatr Nephrol 1999; 13: 347-354.
34. Lukacs-Kornek V, Malhotra D, Fletcher AL et al. Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes. Nat Immunol 2011; 12: 1096-1104.
35. Fine LG, Norman JT, Ong A. Cell-cell cross-talk in the pathogenesis of renal interstitial fibrosis. Kidney Int Suppl 1995; 49: S48-S50.
36. Eitner F, Bucher E, van Roeyen C et al. PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis. J Am Soc Nephrol 2008; 19: 281-289.
37. Cappellesso-Fleury S, Puissant-Lubrano B, Apoil PA et al. Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cells. J Clin Immunol 2010; 30: 607-619.
38. Yamamoto M, Enzan H, Hara H et al. Fluorescence and electron microscopic studies on the perivascular mesenchymal cells and fibroblasts after vitamin A administration. Acta Pathol Jpn 1978; 28: 513-521.
39. Kida Y, Asahina K, Inoue K et al. Characterization of vitamin Astoring cells in mouse fibrous kidneys using Cygb/STAP as a marker of activated stellate cells. Arch Histol Cytol 2007; 70: 95-106.
40. Saxén L. Organogenesis of the Kidney. Cambridge, Cambridge: University Press, 1987.
41. Sequeira Lopez ML, Gomez RA. Development of the renal arterioles. J Am Soc Nephrol 2011; 22: 2156-2165.
42. Cullen-McEwen LA, Caruana G, Bertram JF. The where, what and why of the developing renal stroma. Nephron Exp Nephrol 2005; 99: e1-e8.
43. Dressler GR. The cellular basis of kidney development. Annu Rev Cell Dev Biol 2006; 22: 509-529.
44. Levinson RS, Batourina E, Choi C et al. Foxd1-dependent signals control cellularity in the renal capsule, a structure required for normal renal development. Development 2005; 132: 529-539.
45. Hatini V, Huh SO, Herzlinger D et al. Essential role of stromal mesenchyme in kidney morphogenesis revealed by targeted disruption of Winged Helix transcription factor BF-2. Genes Dev 1996; 10: 1467-1478.
46. Sainio K, Nonclercq D, Saarma M et al. Neuronal characteristics in embryonic renal stroma. Int J Dev Biol 1994; 38: 77-84.
47. Sariola H, Holm K, Henke-Fahle S. Early innervation of the metanephric kidney. Development 1988; 104: 589-599.
48. Itaranta P, Viiri K, Kaartinen V et al. Lumbo-sacral neural crest derivatives fate mapped with the aid of Wnt-1 promoter integrate but are not essential to kidney development. Differentiation 2009; 77: 199-208.
49. Plaisier E, Mougenot B, Verpont MC et al. Glomerular permeability is altered by loss of P0, a myelin protein expressed in glomerular epithelial cells. J Am Soc Nephrol 2005; 16: 3350-3356.
50. Sariola H, Sainio K. Cell lineages in the embryonic kidney: their inductive interactions and signalling molecules. Biochem Cell Biol 1998; 76: 1009-1016.
51. Ding H, Wu X, Bostrom H et al. A specific requirement for PDGFC in palate formation and PDGFR-alpha signaling. Nat Genet 2004; 36: 1111-1116.
52. Humphreys BD, Lin SL, Kobayashi A et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010; 176: 85-97.
53. Kriz W, Kaissling B, Le Hir M. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest 2011; 121: 468-474.
54. Quaggin SE, Kapus A. Scar wars: mapping the fate of epithelialmesenchymal- myofibroblast transition. Kidney Int 2011; 80: 41-50.
55. Grgic I, Duffield JS, Humphreys BD. The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol 2012; 27: 183-193.
56. Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 2010; 21: 212-222.
57. Fragiadaki M, Mason RM. Epithelial-mesenchymal transition in renal fibrosis-evidence for and against. Int J Exp Pathol 2011; 92: 143-150.
58. Zeisberg M, Duffield JS. Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 2010; 21: 1247-1253.
59. Picard N, Baum O, Vogetseder A et al. Origin of renal myofibroblasts in the model of unilateral ureter obstruction in the rat. Histochem Cell Biol 2008; 130: 141-155.
60. Humphreys BD, Valerius MT, Kobayashi A et al. Intrinsic epithelial cells repair the kidney after injury. Cell Stem Cell 2008; 2: 284-291.
61. Faulkner JL, Szcykalski LM, Springer F et al. Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis. Am J Pathol 2005; 167: 1193-1205.
62. Li L, Zepeda-Orozco D, Black R et al. Autophagy is a component of epithelial cell fate in obstructive uropathy. Am J Pathol 2010; 176: 1767-1778.
63. Schrimpf C, Duffield JS. Mechanisms of fibrosis: the role of the pericyte. Curr Opin Nephrol Hypertens 2011; 20: 297-305.
64. Diaz-Flores L, Gutierrez R, Varela H et al. Microvascular pericytes: a review of their morphological and functional characteristics. Histol Histopathol 1991; 6: 269-286.
65. Ru Y, Eyden B, Curry A et al. Actin filaments in human renal tubulo-interstitial fibrosis: significance for the concept of epithelialmyofibroblast transformation. J Submicrosc Cytol Pathol 2003; 35: 221-233.
66. Kilarski WW, Samolov B, Petersson L et al. Biomechanical regulation of blood vessel growth during tissue vascularization. Nat Med 2009; 15: 657-664.
67. Rohatgi R, Flores D. Intratubular hydrodynamic forces influence tubulointerstitial fibrosis in the kidney. Curr Opin Nephrol Hypertens 2010; 19: 65-71.
68. Li L, Zepeda-Orozco D, Patel V et al. Aberrant planar cell polarity induced by urinary tract obstruction. Am J Physiol Renal Physiol 2009; 297: F1526-F1533.
69. Fujigaki Y, Muranaka Y, Sun D et al. Transient myofibroblast differentiation of interstitial fibroblastic cells relevant to tubular dilatation in uranyl acetate-induced acute renal failure in rats. Virchows Arch 2005; 446: 164-176.
70. Boor P, Celec P, Martin IV et al. The peroxisome proliferator-activated receptor-alpha agonist, BAY PP1, attenuates renal fibrosis in rats. Kidney Int 2011; 80: 1182-1197.
71. Boor P, Konieczny A, Villa L et al. PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis. Nephrol Dial Transplant 2007; 22: 1323-1331.
72. Boor P, Konieczny A, Villa L et al. Complement C5 mediates experimental tubulointerstitial fibrosis. J Am Soc Nephrol 2007; 18: 1508-1515.
73. Ostendorf T, Rong S, Boor P et al. Antagonism of PDGF-D by human antibody CR002 prevents renal scarring in experimental glomerulonephritis. J Am Soc Nephrol 2006; 17: 1054-1062.
74. Grgic I, Kiss E, Kaistha BP et al. Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels. Proc Natl Acad Sci USA 2009; 106: 14518-14523.
75. Sorensen I, Susnik N, Inhester T et al. Fibrinogen, acting as a mitogen for tubulointerstitial fibroblasts, promotes renal fibrosis. Kidney Int 2011; 80: 1035-1044.
76. Nakagawa N, Yuhki KI, Kawabe JI et al. The intrinsic prostaglandin E(2)-EP(4) system of the renal tubular epithelium limits the development of tubulointerstitial fibrosis in mice. Kidney Int 2012 doi: 10.1038/ki.2012.115.
77. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev 1995; 75: 487-517.
78. Song Z, Li G. Role of specific microRNAs in regulation of vascular smooth muscle cell differentiation and the response to injury. J Cardiovasc Transl Res 2010; 3: 246-250.
79. Olson LE, Soriano P. PDGFRbeta signaling regulates mural cell plasticity and inhibits fat development. Dev Cell 2011; 20: 815-826.
80. Iwano M, Plieth D, Danoff TM et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341-350.
81. Koesters R, Kaissling B, Lehir M et al. Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol 2010; 177: 632-643.
82. Zeisberg EM, Potenta SE, Sugimoto H et al. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 2008; 19: 2282-2287.
83. Li J, Qu X, Bertram JF. Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am J Pathol 2009; 175: 1380-1388